These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. How I manage cerebral vasculopathy in children with sickle cell disease. Brousse V; Kossorotoff M; de Montalembert M Br J Haematol; 2015 Sep; 170(5):615-25. PubMed ID: 25944412 [TBL] [Abstract][Full Text] [Related]
11. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Hulbert ML; McKinstry RC; Lacey JL; Moran CJ; Panepinto JA; Thompson AA; Sarnaik SA; Woods GM; Casella JF; Inusa B; Howard J; Kirkham FJ; Anie KA; Mullin JE; Ichord R; Noetzel M; Yan Y; Rodeghier M; Debaun MR Blood; 2011 Jan; 117(3):772-9. PubMed ID: 20940417 [TBL] [Abstract][Full Text] [Related]
12. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease. Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886 [TBL] [Abstract][Full Text] [Related]
13. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Switzer JA; Hess DC; Nichols FT; Adams RJ Lancet Neurol; 2006 Jun; 5(6):501-12. PubMed ID: 16713922 [TBL] [Abstract][Full Text] [Related]
14. Sickle cell anemia: intracranial stenosis and silent cerebral infarcts in children with low risk of stroke. Arkuszewski M; Krejza J; Chen R; Ichord R; Kwiatkowski JL; Bilello M; Zimmerman R; Ohene-Frempong K; Melhem ER Adv Med Sci; 2014 Mar; 59(1):108-13. PubMed ID: 24797985 [TBL] [Abstract][Full Text] [Related]
15. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. Adams RJ; Brambilla D; N Engl J Med; 2005 Dec; 353(26):2769-78. PubMed ID: 16382063 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome. Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127 [TBL] [Abstract][Full Text] [Related]
17. Defining stroke risk in children with sickle cell anaemia. Hoppe C Br J Haematol; 2005 Mar; 128(6):751-66. PubMed ID: 15755278 [TBL] [Abstract][Full Text] [Related]
18. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts. King AA; Noetzel M; White DA; McKinstry RC; Debaun MR Pediatr Blood Cancer; 2008 Mar; 50(3):599-602. PubMed ID: 17985350 [TBL] [Abstract][Full Text] [Related]
19. Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. Kwiatkowski JL; Granger S; Brambilla DJ; Brown RC; Miller ST; Adams RJ; Br J Haematol; 2006 Aug; 134(3):333-9. PubMed ID: 16848777 [TBL] [Abstract][Full Text] [Related]
20. The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease. Buchanan ID; James-Herry A; Osunkwo I J Pediatr Hematol Oncol; 2013 Oct; 35(7):543-6. PubMed ID: 23211694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]